Andreas Roller

5PUBLICATIONS
33CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 13, 2026
Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.

|Mar 27, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.

Maria Vieito, Elisa Fontana, Catherine H Han

|Jan 16, 2026
Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors.

Ignacio Melero, Neeltje Steeghs, Ulrik Lassen

|Nov 14, 2025
Identification of conserved immune-related adverse event risk factors and clinical outcomes in a pan-immunotherapy data mart.

David F Lamparter, Virginia C Schmid, Rajat Mohindra

|Apr 22, 2024
Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.

Andreas Roller, Iakov I Davydov, Petra C Schwalie

Pageof 1

Frequent Collaborators

2 joint publications

David J Pinato

2 joint publications

Reinhard Dummer

2 joint publications

Irene Moreno

2 joint publications

Oliver Bechter